WCO classification path
- Chapter30Pharmaceutical products
- Heading3006Pharmaceutical goods specified in note 4 to this chapter
- Subheading300693Placebos and blinded (or double- blinded) clinical trial kits for a recognised clinical trial, put up in measured doses
- National30069300Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses
30069300
"Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses"
HS code 3006930000 (Chapter 30 "Pharmaceutical products"; Heading 3006 "Pharmaceutical goods specified in note 4 to this chapter"; Subheading 300693 "Placebos and blinded (or double- blinded) clinical trial kits for a recognised clinical trial, put up in measured doses") under the Korea tariff schedule classifies "Placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses". Korea customs apply MFN rate of 8, WTO bound rate 0. Statutory unit of measure: KG. This commodity is subject to 1 import regulation or restriction; see compliance section below. 30 free trade agreement preferential rates are available for this code.
Tariff Schedule
| Classification | Rate |
|---|---|
MFN 税率 MFN rate | 8 |
WTO 约束税率 WTO bound rate | 0 |
FTA Preferential Rates
30 agreements available · certificate of origin required
| Agreement | Rate |
|---|---|
| AKFTA (ASEAN-Korea) | 0% |
| KAFTA (Korea-Australia) | 0% |
| CKFTA (Canada-Korea) / CPTPP | 0% |
| Korea-Central America (Costa Rica) | 0% |
| Korea-Central America (Honduras) | 0% |
| Korea-Central America (Nicaragua) | 0% |
| Korea-Central America (Panama) | 0% |
| Korea-Central America (El Salvador) | 0% |
| Korea-Chile | 0% |
| Korea-China | 0% |
| Korea-Colombia | 0% |
| Korea-EU | 0% |
| Korea-UK | 0% |
| Korea-Indonesia (CEPA) | 0% |
| Korea-Israel | 0% |
| Korea-Cambodia | 0% |
| Korea-New Zealand | 0% |
| Korea-Peru | 0% |
| Korea-Singapore | 0% |
| Korea-Turkey | 0% |
| KORUS (Korea-US) | 0% |
| Korea-Vietnam | 0% |
| Korea-EFTA | 4.8% |
| Korea-India (CEPA) | 4% |
| Korea-Philippines | 5.6% |
| RCEP (ASEAN) | 5.3% |
| RCEP (Australia) | 5.3% |
| RCEP (China) | 4% |
| RCEP (Japan) | 4% |
| RCEP (New Zealand) | 5.3% |
Compliance & Controls
1 import regulation, restriction, or permit requirement
약사법
표준통관예정보고서(의약품등)
Global Benchmark
HS-6 prefix 3006.93 across other jurisdictions